NCT06458465View on ClinicalTrials.gov

Impact of Curcumin and Pentoxiphylline on Chronic Kidney Disease Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

October 1, 2024

Conditions
Chronic Kidney Disease
Interventions
DIETARY_SUPPLEMENT

Curcumin

\- Curcumin capsules 500 mg twice daily for 6 months

DRUG

Pentoxifylline 400 MG

\- Pentoxifylline 400 mg twice daily for 6 months.

Trial Locations (1)

21648

Nada Mustafa Kamel, Alexandria

All Listed Sponsors
collaborator

Tanta University

OTHER

lead

Alexandria University

OTHER

NCT06458465 - Impact of Curcumin and Pentoxiphylline on Chronic Kidney Disease Patients | Biotech Hunter | Biotech Hunter